测定59例甲状腺良、恶性疾病患者血清中可溶性白介素受体（SIL- 2 R）。
The study measured serum SIL 2R level in 59 patients with thyroid benign of malignant disease.
已被发现和命名的白介素有19种，其相应的受体大多也已被克隆及鉴定。
There are 19 kinds of mterleukms discovered and designated, and many of their receptors have been cloned and identified.
目的：探讨外周血单个核细胞(PBMC)膜白介素2受体(CD 2 5)表达在肺结核病鉴别诊断中的应用价值。
Objective: to study the value of membrane interleukin 2 receptor (CD25) of peripheral blood mononuclear cells (PBMC) on the differential diagnosis of pulmonary tuberculosis.
目的观察白介素-8受体(IL - 8r)免疫阳性物质在大鼠消化道的存在和分布。
AIM to observe the distribution of interleukin 8 receptor (IL 8r) immunoreactivity in rat digestive tract.
目的：明确白介素- 1受体拮抗剂对变应性鼻炎的治疗作用。
AIM: to determine the effect of interleukin-1 receptor antagonist (IL-lra) on allergic rhinitis.
方法：采用单克隆与多克隆双抗体夹心法测定血清白介素-2 (IL - 2)及可溶性白介素- 2受体(SIL - 2r)水平。
Methods: Monoclonal and poly - clonal dual antibody sandwich method was used to assay the levels of serum interleukin - 2 (IL - 2) and soluble interleukin - 2 receptor (SIL - 2r).
Duerr及其同事(2006)已报道了IBD相关遗传多态性，同样白介素- 23受体的突变。
Duerr and colleagues (2006) have reported that the same variant in the IL-23 receptor is associated with IBD.
白介素及其受体的结构特征决定了其信号转导和功能效应的共性和特性。
The structural patterns of the interieukins and their receptors determine the common and specific nature among the interieukins as well as their receptors.
目的：探索白介素（IL）-22和IL-22相关的细胞因子受体在皮肤黑素瘤细胞中的生物学活性及其相互间的关系。
Objective: To investigate the relationship between IL-22 and its related cytokine receptors in the human melanoma cell line.
目的确定可靠的筛选小分子人白介素6 (IL 6)受体拮抗剂先导化合物的细胞模型。
AIM to confirm R2 cells being reliable cell model to screen small molecular human interleukin-6 (IL-6) receptor antagonists.
目的确定可靠的筛选小分子人白介素6 (IL 6)受体拮抗剂先导化合物的细胞模型。
AIM to confirm R2 cells being reliable cell model to screen small molecular human interleukin-6 (IL-6) receptor antagonists.
应用推荐